Literature DB >> 23806233

Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucose.

Norikazu Tsunekawa-Imai1, Hiroshi Miwa, Masato Shikami, Kazuto Suganuma, Mineaki Goto, Shohei Mizuno, Miyuki Takahashi, Motonori Mizutani, Tomohiro Horio, Hiroko Komatsubara, Mayuko Gotou, Hidesuke Yamamoto, Motohiro Wakabayashi, Masaya Watarai, Ichiro Hanamura, Akira Imamura, Hidetsugu Mihara, Masakazu Nitta.   

Abstract

We examined the effects of diet nutrients on xenotransplanted leukemia cells, THP-1 or NB4. THP-1 tumors showed more growth when fed with high fat diet, while NB4 tumors grew more with high carbohydrate diet. Then, administration of 2-deoxyglucose (a glycolysis inhibitor) showed a significant antitumor effect on both tumors: NB4 tumor showed large necrotic areas, while THP-1 tumor did not, but had augmented expression of enzymes for fatty acid oxidation. 2-Deoxyglucose inhibited the growth of NB4 by cell death because main energy producing pathway (glycolysis) was abolished, while 2-deoxyglucose slowed the growth of THP-1 by shifting energy metabolism to fatty acid β-oxidation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-Deoxyglucose (2-DG); AML; Carbohydrate-dominant diet; Etomoxir; High fat diet; Xenotransplantation

Mesh:

Substances:

Year:  2013        PMID: 23806233     DOI: 10.1016/j.leukres.2013.05.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.

Authors:  Isabel R Schlaepfer; Leah Rider; Lindsey Ulkus Rodrigues; Miguel A Gijón; Colton T Pac; Lina Romero; Adela Cimic; S Joseph Sirintrapun; L Michael Glodé; Robert H Eckel; Scott D Cramer
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

2.  Arachidonic and oleic acid exert distinct effects on the DNA methylome.

Authors:  Guillermo A Silva-Martínez; Dalia Rodríguez-Ríos; Yolanda Alvarado-Caudillo; Alejandro Vaquero; Manel Esteller; F Javier Carmona; Sebastian Moran; Finn C Nielsen; Marie Wickström-Lindholm; Katarzyna Wrobel; Kazimierz Wrobel; Gloria Barbosa-Sabanero; Silvio Zaina; Gertrud Lund
Journal:  Epigenetics       Date:  2016-04-18       Impact factor: 4.528

3.  Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Authors:  Shohei Mizuno; Ichiro Hanamura; Akinobu Ota; Sivasundaram Karnan; Tomoko Narita; Masaki Ri; Motonori Mizutani; Mineaki Goto; Mayuko Gotou; Norikazu Tsunekawa; Masato Shikami; Shinsuke Iida; Yoshitaka Hosokawa; Hiroshi Miwa; Ryuzo Ueda; Masakazu Nitta; Akiyoshi Takami
Journal:  Int J Hematol       Date:  2015-09-04       Impact factor: 2.490

4.  Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress.

Authors:  Mineaki Goto; Hiroshi Miwa; Kazuto Suganuma; Norikazu Tsunekawa-Imai; Masato Shikami; Motonori Mizutani; Shohei Mizuno; Ichiro Hanamura; Masakazu Nitta
Journal:  BMC Cancer       Date:  2014-02-10       Impact factor: 4.430

5.  Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities.

Authors:  María Cristina Estañ; Eva Calviño; Susana Calvo; Beatriz Guillén-Guío; María Del Carmen Boyano-Adánez; Elena de Blas; Eduardo Rial; Patricio Aller
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

Review 6.  Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling.

Authors:  Shinichiro Takahashi
Journal:  Leuk Res Rep       Date:  2019-11-27

7.  High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells.

Authors:  François Hermetet; Rony Mshaik; John Simonet; Patrick Callier; Laurent Delva; Ronan Quéré
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.